XML 37 R25.htm IDEA: XBRL DOCUMENT v3.25.2
SUPPLEMENTAL BALANCE SHEET DETAILS (Tables)
6 Months Ended
Jun. 29, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Accounts Receivable Accounts Receivable
In millionsJune 29,
2025
December 29,
2024
Trade accounts receivable, gross$709 $744 
Allowance for credit losses(8)(9)
Total accounts receivable, net$701 $735 
Schedule of Inventory
Inventory
In millionsJune 29,
2025
December 29,
2024
Raw materials$227 $225 
Work in process419 404 
Finished goods47 31 
Inventory, gross693 660 
Inventory reserve(118)(113)
Total inventory, net$575 $547 
Schedule of Accrued Liabilities
Accrued Liabilities
In millionsJune 29,
2025
December 29,
2024
Contract liabilities, current portion$247 $260 
Accrued compensation expenses (1)
214 252 
Accrued taxes payable75 101 
Operating lease liabilities, current portion79 79 
Other, including warranties (2)
147 135 
Total accrued liabilities$762 $827 
_____________
(1)Includes employee separation costs related to restructuring activities.
(2)See table below for changes in the reserve for product warranties.
Schedule of Changes in Reserve for Product Warranties
Changes in the reserve for product warranties were as follows:
In millionsQ2 2025Q2 2024YTD 2025YTD 2024
Balance at beginning of period$17 $20 $18 $21 
Additions charged to cost of product revenue6 10 14 22 
Repairs and replacements(7)(13)(16)(26)
Balance at end of period$16 $17 $16 $17 
Schedule Of Restructuring and Related Costs
A summary of the pre-tax restructuring charges is as follows:

In millionsQ2 2025Q2 2024YTD 2025YTD 2024
Cumulative charges recorded since inception
Employee separation costs$8 $$39 $$99 
Asset impairment charges (1)
 —  32 146 
Other costs  8 
Total restructuring charges (2)
$8 $$39 $40 $253 
_____________
(1)For YTD 2024, primarily relates to impairment of right-of-use assets and leasehold improvements for our Foster City campus.
(2)For Q2 2025, $4 million was recorded in R&D expense, $3 million in SG&A expense, with remainder in cost of revenue.
For YTD 2025, $22 million was recorded in SG&A expense, $14 million in R&D expense, with remainder in cost of revenue.
For Q2 2024, $4 million was recorded in SG&A expense. For YTD 2024, $39 million was recorded in SG&A expense, with remainder in R&D expense. Restructuring charges for Q2 2024 and YTD 2024 primarily related to Core Illumina segment.
A summary of restructuring liability activity during YTD 2025 is as follows:

In millions
Employee Separation Costs (1)
Other CostsTotal
Amount recorded in accrued liabilities as of December 29, 2024
$$$
Additional expense recorded
39 — 39 
Cash payments
(20)(2)(22)
Adjustments to accrual
(2)— (2)
Amount recorded in accrued liabilities as of June 29, 2025
$19 $— $19 
Estimated costs to still be incurred
$(3)$— $(3)
_____________
(1)It is expected that substantially all of the employee separation related charges will be incurred and paid by the end of Q4 2025.